Effectiveness and economic impact of a diabetes education program among adults with type 2 diabetes in South Texas

Table 4 Estimated direct medical cost savings from the program using the Bansal approach

Number of Type 2 diabetes participants at 12-month ^a			Number of Type 2 Diabetes participants at baseline
- with baseline A1c > =9%		80	- with baseline A1c > =9%			1375
- A1c decreased at 12-month		67	- A1c decreased at 12-month (extrapolated)			1152
Estimated cost savings from followed participants (12 month) in 2 years post training
Direct medical cost savings	1st year (per patient)^b	2nd year (per patient)^b	1st year post DEP (based on 12-month follow-up)^c	2nd year post DEP (based on 12-month follow-up)^c	1st year post DEP (estimated total program saving)^d	2nd year post DEP (estimated total program saving)^d
Medical	2123	1236	142,241	82,812	2,445,696	1,423,872
Inpatient	510	476	34,170	31,892	587,520	548,352
Outpatient	1597	743	106,999	49,781	1,839,744	855,936
-ER	17	16	1139	1072	19,584	18,432
Pharmacy	288	394	19,296	26,398	331,776	453,888
Others	92	60	6164	4020	105,984	69,120
Total (2014 USD)	2503	1690	167,701	113,230	2,883,456	1,946,880
Total (2018 USD)	2780	1877	186,247	125,752	3,202,560	2,162,179

^a Estimates are from the program
^b individual cost savings are from Bansal 2018, cost saving only apply to patients with baseline A1c > =9% and decreased compared to the ones with baseline A1c > =9% and not decreased post index date
^c program cost savings were estimated by multiplying per patient per year cost by the number of qualified program participants at 12-month follow-up
^d program cost savings were estimated by multiplying per patient per year cost by the estimated number of total qualified program participants

ISSN: 1471-2458